Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients With Acute Respiratory Failure and Sepsis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Boeckh, MD
Fred Hutchinson Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Colorado Denver
Denver, Colorado, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Brigham & Women'S Hospital
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Washington University
St Louis, Missouri, United States
- Montefioure Medical Center
The Bronx, New York, United States
- Duke University
Durham, North Carolina, United States
- Wakeforest University, School of Medicine
Winston-Salem, North Carolina, United States
- University of Cincinnati
Cincinnati, Ohio, United States
- the Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Ohio State University Medical Center
Columbus, Ohio, United States
- University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
- Medical College of South Carolina
Charleston, South Carolina, United States
- Vanderbilt University
Nashville, Tennessee, United States
- Intermountain Medical Center
Murray, Utah, United States
- University of Vermont College of Medicine
Burlington, Vermont, United States
- Harborview Medical Center
Seattle, Washington, United States
- University of Washington Medical Center
Seattle, Washington, United States
- University of Wisconsin School of Medicine & Public Health
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Jun 2021
- Primary completion
- 25 Oct 2024
- Completion
- 8 Apr 2025
- Last update posted
- 12 Dec 2025
- Registered enrollment
- 205
- Registry id
- NCT04706507
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.